featured

Use this feature to promote an article to the front page.

Application of DSM-5 Criteria for Autism Spectrum Disorder to Three Samples of Children With DSM-IV Diagnoses of Pervasive Developmental Disorders

Source: 
The American Journal of Psychiatry
Date Published: 
October 1, 2012
Year Published: 
2012
Abstract: 

Substantial revisions to the DSM-IV criteria for autism spectrum disorders (ASDs) have been proposed in efforts to increase diagnostic sensitivity and specificity. This study evaluated the proposed DSM-5 criteria for the single diagnostic category of autism spectrum disorder in children with DSM-IV diagnoses of pervasive developmental disorders (PDDs) and non-PDD diagnoses.

ASF's Brain Tissue Donation Awareness Campaign Featured in Disability Scoop

Source: 
Disability Scoop
Date Published: 
October 2, 2012
Abstract: 

After many of the world’s brain samples available for autism research were lost earlier this year, a new effort is underway to increase tissue donation from those with the disorder.

Autism Science Foundation to Develop Brain Tissue Donation Awareness Campaign with Support from Simons Foundation

Date Published: 
October 1, 2012
Abstract: 

ASF received a two-year, $600,000 grant from the Simons Foundation to develop a multi-media campaign designed to increase awareness of the importance of brain tissue donation to further autism research.

2-year grant from the Simons Foundation will support multi-media campaign designed to support and encourage brain tissue donation for autism research

(October 1, 2012—New York, NY)--The Autism Science Foundation, a not-for-profit organization dedicated to supporting and funding autism research, today announced that it had received a two-year, $600,000 grant from the Simons Foundation to develop a multi-media campaign designed to increase awareness of the importance of brain tissue donation to further autism research. 

"No effort is more important than raising awareness among families and scientists about the need for research on human brain tissue,” said Dr. Gerald Fischbach, Director of the Simons Foundation Autism Research Initiative. “At this point, we have learned a great deal about the genetics of autism, and have important animal models with which to test genetic hypotheses. And now the next step in developing useful therapies, and even possibly preventative measures, depends on understanding more about the human brain itself.  This project is designed to help children on the autism spectrum, and although brain donation is a difficult issue for many, it is one of the best ways to help families."

“In every area of medicine,” said Dr. Thomas Insel, Director of the National Institute of Mental Health, “new diagnostics and new treatments have come from studying the affected organ.  In autism, we have been challenged by trying to understand a complex neurodevelopmental disorder without having enough brain tissue available for study.  This is especially unfortunate because today we have such powerful tools to interrogate any tissue that becomes available. This new public-private effort, called for by the Interagency Autism Coordinating Committee Strategic Plan for Research, can launch a national effort to increase brain tissue donation.  In so many ways, our ability to deliver for families with autism depends on the success of this effort.”

ASF President Alison Singer will serve as principal investigator on the project. Prior to founding the Autism Science Foundation, Singer served as Executive Vice President for Communications and Awareness at Autism Speaks, where she developed and co-produced the award-winning “The Odds” autism awareness campaign in conjunction with the Ad Council.

“The need for more autism brain tissue is consistently described as a major roadblock to advancing autism research” said Singer, who also serves as a public member of the Interagency Autism Coordinating Committee. “We know that parents in our community are eager to do everything possible to move the research forward and this campaign will give them the information and tools they need to determine whether tissue donation is right for them.”

The Autism Science Foundation is a 501(c)(3) public charity. Its mission is to support autism research by providing funding to scientists and organizations conducting, facilitating, publicizing and disseminating autism research. The organization also provides information about autism to meeting the needs of individuals and families affected by autism.

ASF recently released a request for applications for pre and post doctoral fellowships. In the past 3 years ASF has funded close to a million dollars in training grants. Additional information about the RFA can be found at www.autismsciencefoundation.org/ApplyForaGrant.html. The application deadline is November 16, 2012.

To learn more about the Autism Science Foundation’s programs visit www.autismsciencefoundation.org

 

--30--

Contact Info:    

Dawn Crawford
Events and Media Manager
Autism Science Foundation
dcrawford@autismsciencefoundation.org

 

Autism Science Foundation to Develop Brain Tissue Donation Awareness Campaign with Support from Simons Foundation

ASF President Alison Singer Comments on National Funding for Autism Research in the Pittsburgh Post-Gazette

Source: 
Pittsburgh Post-Gazette
Date Published: 
October 1, 2012
Abstract: 

"The universities that were on the list were worthy of being funded" said Alison Singer, president of the Autism Science Foundation, "but there are many other projects that were deserving and critically important that were not funded. The problem is, the list is just too short. With all that we've learned in recent years, this is the time in autism research to step on the gas, not the brake."

ASF President Alison Singer Named an "Autism Champion" by the American Academy of Pediatrics

Source: 
American Academy of Pediatrics
Date Published: 
October 1, 2012
Abstract: 

A note from the publisher..."From autism and Asperger's syndrome through pervasive developmental disorders, this authoritative reference from the leading publisher in pediatric health care examines how autism spectrum disorders (ASDs) are defined and diagnosed and reviews the most current behavioral and developmental therapy treatments available. Through this evidence-based guide, which reflects the new diagnostic thinking from the American Psychiatric Association, parents and caregivers will learn about the symptoms and the incidence of ASDs, screening tools, the roles of complementary and alternative medicine, and what to expect as these children grow into adolescence and beyond."

Announcing the Autism Brain Imaging Data Exchange, a Database of Brain Scans from Over 15 Medical and Research Institutions Worldwide

Source: 
Enhanced Online News
Date Published: 
September 24, 2012
Abstract: 

Researchers officially announce the creation of the Autism Brain Imaging Data Exchange, a database of previously collected brain scans from over 15 medical and research institutions worldwide. The founders aim to advance scientific understanding of ASD through this data sharing initiative.

Progress in Identifying the Genetic Roots of Autism

Source: 
Wall Street Journal
Date Published: 
September 25, 2012
Abstract: 

Genetic tests are beginning to shed light on the causes of some autism spectrum disorders.

IMFAR 2013 Call for Abstracts

Source: 
INSAR
Date Published: 
September 10, 2012
Abstract: 

The IMFAR Scientific Program Committee invites abstract, scientific panel, educational symposium and technology demonstration submissions for review in all disciplines relevant to autism research for presentation at the 2013 IMFAR meeting in Donostia / San Sebastián, Spain being held May 2-4 2013.

What the DSM-5 Portends for Research, Diagnosis, and Treatment of Autism Spectrum Disorders.

Source: 
Current Psychiatry Reports
Date Published: 
September 19, 2012
Abstract: 

With the impending release of DSM-5, this article reviews proposed changes related to ASD diagnosis and discusses possible implications of DSM-5 changes on autism treatment and research.

Experimental Drug may Treat Social Withdrawal Symptoms in Individuals with Fragile X Syndrome, the Most Common Known Genetic Cause of Autism.

Source: 
Science Translational Medicine
Date Published: 
September 19, 2012
Abstract: 

Arbaclofen, also known as STX209, shows promise in its treatment of social symptoms associated with fragile x syndrome.